Guidelines For Clinical Practice
Copyright ©2010 Baishideng.
World J Gastroenterol. May 28, 2010; 16(20): 2463-2467
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2463
Table 1 Carcinogenic factors involved in hepatocellular carcinoma in patients with type B cirrhosis[1]
VariablenUnivariate analysis
Multivariate analysis
P-value1RR295% CIP-value3RR295% CI
ALT (IU/L)
≥ 100140.00832.0441.098-4.6770.0254.5251.202-17.030
< 100511.0001.000
LDH (IU/L)
≥ 480300.01382.0000.878-4.558NS (0.081)2.8800.881-9.412
< 480351.0001.000
HBV-DNA (LGE/mL)
≥ 3.7460.00822.8361.269-6.3400.0147.7121.511-39.365
< 3.7191.0001.000